217 related articles for article (PubMed ID: 15579765)
1. Growth hormone therapy in children after cranial/craniospinal radiation therapy: sexually dimorphic outcomes.
Lerner SE; Huang GJ; McMahon D; Sklar CA; Oberfield SE
J Clin Endocrinol Metab; 2004 Dec; 89(12):6100-4. PubMed ID: 15579765
[TBL] [Abstract][Full Text] [Related]
2. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study.
Brownstein CM; Mertens AC; Mitby PA; Stovall M; Qin J; Heller G; Robison LL; Sklar CA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4422-7. PubMed ID: 15356041
[TBL] [Abstract][Full Text] [Related]
3. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
Gleeson HK; Stoeter R; Ogilvy-Stuart AL; Gattamaneni HR; Brennan BM; Shalet SM
J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
[TBL] [Abstract][Full Text] [Related]
4. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
5. Response to growth hormone treatment and final height after cranial or craniospinal irradiation.
Sulmont V; Brauner R; Fontoura M; Rappaport R
Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044
[TBL] [Abstract][Full Text] [Related]
6. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
7. Final height and weight of long-term survivors of childhood malignancies.
Müller HL; Klinkhammer-Schalke M; Kühl J
Exp Clin Endocrinol Diabetes; 1998; 106(2):135-9. PubMed ID: 9628245
[TBL] [Abstract][Full Text] [Related]
8. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
Saggese G; Federico G; Barsanti S; Fiore L
J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
[TBL] [Abstract][Full Text] [Related]
9. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
[TBL] [Abstract][Full Text] [Related]
10. Growth response to growth hormone therapy following craniospinal irradiation.
Clayton PE; Shalet SM; Price DA
Eur J Pediatr; 1988 Aug; 147(6):597-601. PubMed ID: 3181200
[TBL] [Abstract][Full Text] [Related]
11. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
[TBL] [Abstract][Full Text] [Related]
12. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
[TBL] [Abstract][Full Text] [Related]
13. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years.
Paul D; Conte FA; Grumbach MM; Kaplan SL
J Clin Endocrinol Metab; 1995 Feb; 80(2):546-51. PubMed ID: 7852518
[TBL] [Abstract][Full Text] [Related]
16. [Growth hormone treatment in childhood cancer survivors].
Sampaio M; Oliveira A; Soro I; Costa C; Castro-Correia C; Fontoura M
Acta Med Port; 2011 Dec; 24 Suppl 2():393-8. PubMed ID: 22849927
[TBL] [Abstract][Full Text] [Related]
17. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
[TBL] [Abstract][Full Text] [Related]
18. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
van Gool SA; Kamp GA; Visser-van Balen H; Mul D; Waelkens JJ; Jansen M; Verhoeven-Wind L; Delemarre-van de Waal HA; de Muinck Keizer-Schrama SM; Leusink G; Roos JC; Wit JM
J Clin Endocrinol Metab; 2007 Apr; 92(4):1402-8. PubMed ID: 17284626
[TBL] [Abstract][Full Text] [Related]
19. Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.
Beckers D; Thomas M; Jamart J; Francois I; Maes M; Lebrethon MC; De Waele K; Tenoutasse S; De Schepper J
Eur J Endocrinol; 2010 Mar; 162(3):483-90. PubMed ID: 19969557
[TBL] [Abstract][Full Text] [Related]
20. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
